Company Description
Labcorp Holdings Inc. provides laboratory services.
It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests.
It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs).
In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing.
It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers.
The company was founded in 1995 is headquartered in Burlington, North Carolina.
| Country | United States |
| Founded | 1971 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 70,000 |
| CEO | Adam Schechter |
Contact Details
Address: 358 South Main Street Burlington, North Carolina 27215 United States | |
| Phone | 336 229 1127 |
| Website | labcorp.com |
Stock Details
| Ticker Symbol | LH |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000920148 |
| CUSIP Number | 504922105 |
| ISIN Number | US5049221055 |
| Employer ID | 99-2588107 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Glenn A. Eisenberg | Executive Vice President and Special Advisor to the Chief Executive Officer |
| Adam H. Schechter | President, Chief Executive Officer and Chairman |
| Mark S. Schroeder | Executive Vice President, President of Diagnostics Laboratories and Chief Operating Officer |
| Dr. Brian J. Caveney J.D., M.D., M.P.H. | EVice President, President of Early Development Research Laboratories and Chief Medical and Scientific Officer |
| Anita Z. Graham | Executive Vice President and Chief Human Resources Officer |
| Julia Wang | Chief Financial Officer and Executive Vice President |
| Peter J. Wilkinson | Senior Vice President and Chief Accounting Officer |
| Akinbolade Oyegunwa M.B.A., Ph.D. | Executive Vice President and Chief Information and Technology Officer |
| Christin O'Donnell | Vice President of Investor Relations |
| Sandra D. van der Vaart J.D. | Executive Vice President, Chief Legal Officer and Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 28, 2025 | 144 | Filing |
| Mar 28, 2025 | 144 | Filing |
| Mar 5, 2025 | 144 | Filing |
| Feb 28, 2025 | 144 | Filing |
| Feb 25, 2025 | 10-K | Annual Report |
| Feb 25, 2025 | 144 | Filing |
| Feb 24, 2025 | 144 | Filing |
| Feb 11, 2025 | 144 | Filing |
| Feb 6, 2025 | 8-K | Current Report |
| Jan 31, 2025 | 8-K | Current Report |